A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
25 participants needed
1 Location
Brief description of study
This is an observational study to determine what types of medications patients take to treat MCL as well as how patients respond to those medications.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Mantle Cell Lymphoma
-
Age: 18 years - 99 years
-
Gender: All
Male and Female 18 years of age and older DX of Mantle Cell Lymphoma
Updated on
04 Aug 2024.
Study ID: 832604
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
